Daniel Liebler
Faculty Member
Last active: 2/15/2016

  1. Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. Tabb DL, Vega-Montoto L, Rudnick PA, Variyath AM, Ham AJ, Bunk DM, Kilpatrick LE, Billheimer DD, Blackman RK, Cardasis HL, Carr SA, Clauser KR, Jaffe JD, Kowalski KA, Neubert TA, Regnier FE, Schilling B, Tegeler TJ, Wang M, Wang P, Whiteaker JR, Zimmerman LJ, Fisher SJ, Gibson BW, Kinsinger CR, Mesri M, Rodriguez H, Stein SE, Tempst P, Paulovich AG, Liebler DC, Spiegelman C (2010) J Proteome Res 9(2): 761-76
    › Primary publication · 19921851 (PubMed) · PMC2818771 (PubMed Central)
  2. Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. Regnier FE, Skates SJ, Mesri M, Rodriguez H, Tezak Z, Kondratovich MV, Alterman MA, Levin JD, Roscoe D, Reilly E, Callaghan J, Kelm K, Brown D, Philip R, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Ransohoff DF, Mansfield E, Anderson NL (2010) Clin Chem 56(2): 165-71
    › Primary publication · 20007858 (PubMed)
  3. Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses. Rudnick PA, Clauser KR, Kilpatrick LE, Tchekhovskoi DV, Neta P, Blonder N, Billheimer DD, Blackman RK, Bunk DM, Cardasis HL, Ham AJ, Jaffe JD, Kinsinger CR, Mesri M, Neubert TA, Schilling B, Tabb DL, Tegeler TJ, Vega-Montoto L, Variyath AM, Wang M, Wang P, Whiteaker JR, Zimmerman LJ, Carr SA, Fisher SJ, Gibson BW, Paulovich AG, Regnier FE, Rodriguez H, Spiegelman C, Tempst P, Liebler DC, Stein SE (2010) Mol Cell Proteomics 9(2): 225-41
    › Primary publication · 19837981 (PubMed) · PMC2830836 (PubMed Central)
  4. Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance. Paulovich AG, Billheimer D, Ham AJ, Vega-Montoto L, Rudnick PA, Tabb DL, Wang P, Blackman RK, Bunk DM, Cardasis HL, Clauser KR, Kinsinger CR, Schilling B, Tegeler TJ, Variyath AM, Wang M, Whiteaker JR, Zimmerman LJ, Fenyo D, Carr SA, Fisher SJ, Gibson BW, Mesri M, Neubert TA, Regnier FE, Rodriguez H, Spiegelman C, Stein SE, Tempst P, Liebler DC (2010) Mol Cell Proteomics 9(2): 242-54
    › Primary publication · 19858499 (PubMed) · PMC2830837 (PubMed Central)
  5. Final safety assessment of thiodipropionic acid and its dialkyl esters as used in cosmetics. Diamante C, Fiume MZ, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F (2010) Int J Toxicol 29(4 Suppl): 137S-50S
    › Primary publication · 20634504 (PubMed)
  6. Final report of the safety assessment of Kojic acid as used in cosmetics. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2010) Int J Toxicol 29(6 Suppl): 244S-73
    › Primary publication · 21164073 (PubMed)
  7. Final report of the Cosmetic Ingredient Review Expert Panel amended safety assessment of Calendula officinalis-derived cosmetic ingredients. Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW (2010) Int J Toxicol 29(6 Suppl): 221S-43
    › Primary publication · 21164072 (PubMed)
  8. Final amended safety assessment of hydroquinone as used in cosmetics. Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW (2010) Int J Toxicol 29(6 Suppl): 274S-87
    › Primary publication · 21164074 (PubMed)
  9. DNA-protein cross-linking by 1,2,3,4-diepoxybutane. Michaelson-Richie ED, Loeber RL, Codreanu SG, Ming X, Liebler DC, Campbell C, Tretyakova NY (2010) J Proteome Res 9(9): 4356-67
    › Primary publication · 20666492 (PubMed) · PMC2956319 (PubMed Central)
  10. Depletion of abundant plasma proteins and limitations of plasma proteomics. Tu C, Rudnick PA, Martinez MY, Cheek KL, Stein SE, Slebos RJ, Liebler DC (2010) J Proteome Res 9(10): 4982-91
    › Primary publication · 20677825 (PubMed) · PMC2948641 (PubMed Central)